SCHEMBL2566258

SCHEMBL2566258

CCC(C)c1ccc(NC(=O)c2cccc(OC)c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.66
RAB9A P51151 7/20 0.66
SMN1; SMN2 Q16637 5/20 0.66
TP53 P04637 5/20 0.66
KDM4E B2RXH2 2/20 0.66
TSHR P16473 2/20 0.66
NFKB1 P19838 1/20 0.66
NFKB2 Q00653 1/20 0.66
RELA Q04206 1/20 0.66
KMT2A Q03164 7/20 0.64
MEN1 O00255 6/20 0.64
ALDH1A1 P00352 4/20 0.64
PKM P14618 1/20 0.64
HPGD P15428 1/20 0.64
MAPK1 P28482 1/20 0.64
POLB P06746 2/20 0.64
MAPT P10636 2/20 0.64
AR P10275 1/20 0.60
NPSR1 Q6W5P4 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21348648 0.89 RXFP1 (0.65) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL13139983 0.88 NPC1 (0.66) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL17660209 0.87 NPC1 (0.72) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL6802217 0.82 NPC1 (0.83) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL2564458 0.82 RAB9A (0.62) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL2564961 0.81 NPC1 (0.71) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL8363735 0.80 NPC1 (1.00) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL5400469 0.80 AR (0.89) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL12167724 0.80 AR (0.89) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL5226157 0.80 NPC1 (1.00) NPC1RAB9ASMN1; SMN2TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2382194-A2 COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE RESVERLOGIX CORP. (CA) 2011-11-02 EP disclosed